These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37078213)

  • 21. [Construction and evaluation of dual-effect cord blood natural killer cells expressing highaffinity PD-1 and chimeric antigen CD19 receptor].
    Zhong H; Zou Q; Liu H; Wang X; DU S; Liang H; Wu Z; Ye J; Zou Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1877-1884. PubMed ID: 35012922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of PD1/CD28 chimeric-switch receptor enhances anti-tumor ability of c-Met CAR-T in gastric cancer.
    Chen C; Gu YM; Zhang F; Zhang ZC; Zhang YT; He YD; Wang L; Zhou N; Tang FT; Liu HJ; Li YM
    Oncoimmunology; 2021 Mar; 10(1):1901434. PubMed ID: 33854821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity].
    Chen GH; Huang HW; Wang Y; Liu HW; Xu LJ; Ma X; Xue SL; He XF; Wang Y; Gu B; Li CX; Qiu HY; Tang XW; Jin ZM; Miao M; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):148-152. PubMed ID: 29562451
    [No Abstract]   [Full Text] [Related]  

  • 24. [Establishment of a cytokine release syndrome associated with chimeric antigen receptor T cell treatment in SCID/Beige mice model].
    Shan JQ; Nan SF; Li F; Shen CY; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1248-1254. PubMed ID: 34915632
    [No Abstract]   [Full Text] [Related]  

  • 25. HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met.
    Ma H; Wei W; Liang D; Xu X; Yang D; Wang Q; Wang Y; Wei Q; Sun B; Zhao X
    Immunol Invest; 2023 Nov; 52(6):735-748. PubMed ID: 37409941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of sodium iodide symporter co-expression on proliferation and cytotoxic activity of chimeric antigen receptor T cells
    Tian C; Huang P; He Y; Wang L; Peng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):1062-1068. PubMed ID: 35869771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting CDH17 with Chimeric Antigen Receptor-Redirected T Cells in Small Cell Lung Cancer.
    Tian W; Zhao J; Wang W
    Lung; 2023 Oct; 201(5):489-497. PubMed ID: 37823901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killing cervical cancer cells by specific chimeric antigen receptor-modified T cells.
    He Y; Li XM; Yin CH; Wu YM
    J Reprod Immunol; 2020 Jun; 139():103115. PubMed ID: 32199196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bioinformatic prediction and validation of cellular-mesenchymal epithelial transition(c-Met) as a target for chimeric antigen receptor T (CAR-T) cell therapy in the treatment of colorectal cancer].
    Peng S; Min J; Long C; Xie Z; Zhang L; Li H; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jul; 40(7):614-622. PubMed ID: 39179404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer.
    Li J; Hu H; Lian H; Yang S; Liu M; He J; Cao B; Chen D; Hu Y; Zhi C; Shen Y; Ye X; He B; Zhao M; Fan W; Xu L; Leidner R; Wu Q; Yang L; Zhang Z
    Int J Biol Sci; 2024; 20(5):1578-1601. PubMed ID: 38481806
    [No Abstract]   [Full Text] [Related]  

  • 31. Construction and Characterization of Cadherin 6 (CDH6)-Targeting Chimeric Antigen Receptor (CAR) Modified T Cells.
    Pang L; Ren F; Xu X; Fu L; Wang T; Guo Z
    J Environ Pathol Toxicol Oncol; 2022; 41(1):55-71. PubMed ID: 35378004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Construction and function of Glypican-3-targeted fourth-generation chimeric antigen receptor T cells (secreting IL-7 and CCL19)].
    Huang W; Liu Y; Hu Y; Gao J
    Sheng Wu Gong Cheng Xue Bao; 2020 May; 36(5):979-991. PubMed ID: 32567281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annihilation of Non-small Cell Lung Cancer by NKG2D CAR-T Cells Produced from T Cells from Peripheral Blood of Healthy Donors.
    Jiang J; Liu Y; Zeng Y; Fang B; Chen Y
    J Interferon Cytokine Res; 2023 Oct; 43(10):445-454. PubMed ID: 37819621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer.
    Zhong M; Chalbatani GM; Deng M; Li Q; Gharagouzloo E; Hamblin MR; Suarez ER; Hu L; Wang D
    Eur J Pharm Sci; 2023 Jan; 180():106331. PubMed ID: 36384203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity].
    Zhang CX; Cheng H; Han X; Qi KM; Chen W; Wu QY; Cao J; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):465-470. PubMed ID: 30032561
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma.
    Wang J; Wang Y; Pan H; Zhao L; Yang X; Liang Z; Shen X; Zhang J; Yang J; Zhu Y; Xun J; Liang Y; Lin Q; Liang H; Li M; Zhu H
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.
    Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H
    J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preliminary study of the fourth-generation CAR-T cells targeting CS1 in the treatment of refractory and recurrent multiple myeloma].
    Feng DD; Chen XH; Guo JJ; Wang KK; Zhang XM; Gao JM
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):657-665. PubMed ID: 34289557
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of Special Structure Bi-Specific Chimeric Antigen Receptor T Cell on Tumor Cells].
    Liu C; Peng H; Zeng WJ; Li W; Chen KK; Li WT; Zeng GF; Liang X; Hu JY; Zhou M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1730-1740. PubMed ID: 36476896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia.
    Wang XY; Bian MR; Lin GQ; Yu L; Zhang YM; Wu DP
    Eur J Haematol; 2024 Jan; 112(1):83-93. PubMed ID: 37712633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.